Benfotiamine
苯磷硫胺素
Report date: 2026/03/06 20:02:51
NME
Base Information
Drug NameBenfotiamine
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesN/A
China Registration ClassN/A
Develop Information
Active CompaniesShanghai Rixin Pharmaceutical Technology Co LtdBenfovir AGBurke Neurological Institute
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A